There are some big caveats on obesity though, IMO:
- To state the obvious, Race would have to prove it could work as an anti-obesity agent through clinical research.
- Then, it's a different game to get it approved. FDA may eagerly approve salvage drugs for patients in advanced cancer stage, given it is a life-or-death situation which outweights any potential risks for patients. In comparison, obesity is not life-threatening and would be scrutinised for side effects. Back in 2006, Sanofi got burnt with Acomplia.
Case: Accomplia/Rimonabant is a a cannabinoid receptor antagonist that blocks the signals of hunger. The drug worked very well and was was approved, expected to be a blockbuster, but some patients anecdotically reported an increase in depression/suicidal thoughts. which pushed FDA and other regulators to withdraw approval. Acomplia when from blockbuster to bust.
https://www.fiercepharma.com/special-report/acomplia-pharma-s-biggest-flops
Bisantrene has a totally different acting mechanism compared to Acomplia. Instead of interfering with brain signals it actually meddles with cell/DNA reproduction, which from my unqualified opinion would place it much higher on the scale of risks.
IMHO and would be great to have an expert opinion on this. Dr T perhaps?
- Forums
- ASX - By Stock
- RAC
- Pillar 1 - FTO (new thread)
Pillar 1 - FTO (new thread), page-36
- There are more pages in this discussion • 2,868 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.080(5.67%) |
Mkt cap ! $248.7M |
Open | High | Low | Value | Volume |
$1.43 | $1.50 | $1.43 | $226.3K | 155.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19787 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.50 | 36493 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19787 | 1.490 |
1 | 1750 | 1.485 |
1 | 3113 | 1.470 |
2 | 2970 | 1.460 |
2 | 17500 | 1.450 |
Price($) | Vol. | No. |
---|---|---|
1.500 | 36493 | 6 |
1.520 | 1757 | 1 |
1.525 | 7788 | 1 |
1.530 | 12300 | 1 |
1.550 | 1000 | 1 |
Last trade - 14.15pm 13/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.51 |
  |
Change
0.080 ( 9.07 %) |
|||
Open | High | Low | Volume | ||
$1.45 | $1.53 | $1.44 | 12074 | ||
Last updated 14.47pm 13/05/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
MGU
MAGNUM MINING AND EXPLORATION LIMITED
Neil Goodman, MD
Neil Goodman
MD
SPONSORED BY The Market Online